Blog
Latest articles, insights, and updates from the blog.
Oral Neurosteroid Delivery Could Reshape Depression Care
Monash University's GlyphAllo delivers allopregnanolone orally via fat pathways. Here's what this means for ketamine therapy patients and the depression treatment landscape.
Chatbots Feel More Judgmental Than Humans, Study Finds
A new study flips the script on AI mental health tools: people feel more judged by chatbots than humans. What this means for ketamine therapy intake.
Brain Fear Circuits Reveal PTSD Clues for Ketamine Care
Tulane researchers mapped circuits that regulate fear as threats fade. Here's what it means for PTSD patients considering ketamine therapy in 2026.
Ultrasound May Speed Fear Extinction in the Brain
New research shows focused ultrasound can help the brain overcome fear faster — a finding with direct implications for ketamine-assisted trauma treatment.
Amygdala Astrocytes Drive Anxiety, Not Just Support It
New research in Neuron shows amygdala astrocytes actively regulate anxiety and threat assessment — with direct implications for ketamine's mechanism of action.
Ketamine in Pregnancy and Lactation: Safety Considerations and Data Gaps
Comprehensive review of ketamine safety in pregnancy and lactation, examining preclinical developmental toxicity, limited human data, breastfeeding transfer, and risk-benefit framework.
Ketamine Tolerance and Long-Term Use: What Clinicians Need to Know
Clinical review of tolerance development during long-term ketamine therapy, including mechanisms, detection strategies, and evidence-based management approaches.
Managing Nausea and Vomiting During Ketamine Therapy
Clinical guide to preventing and treating ketamine-induced nausea and vomiting, covering antiemetic protocols, risk factors, and non-pharmacological strategies.
Long-Term Safety Considerations for Ketamine Therapy
An evidence-based review of safety concerns associated with repeated or prolonged low-dose ketamine use, including urological toxicity, neurocognitive effects, hepatic complications, and the potential for psychological and physiological dependence.
How Long Do Ketamine Side Effects Last?
Most ketamine side effects resolve within 1 to 2 hours after an infusion ends, with subtle residual effects fading within 4 to 6 hours.
Ketamine and SSRIs: Drug Interaction Deep Dive
A clinician-focused analysis of pharmacological interactions between ketamine and selective serotonin reuptake inhibitors, covering serotonin syndrome risk, clinical evidence on concurrent use, and dosing adjustment considerations.
Ketamine and Bladder Health: Urological Safety at Therapeutic Doses
A clinical review of ketamine-associated urological toxicity, examining the evidence at recreational versus therapeutic dose levels, pathophysiological mechanisms, risk factors, monitoring recommendations, and protective strategies for patients receiving low-dose ketamine treatment.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.